Alembic Pharma gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity

Alembic Pharma gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity "The company has received final approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tizanidine Hydrochloride Capsules, 2 mg, 4 mg, and 6 mg," the drug firm said in a regulatory filing.

No comments:

Post a Comment